YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[View of Moderna office entrance with logo sign, Biotechnology industry] Veronique D Shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) have rallied 202% since Aug. 18, fueled by positive news about the biotech company's exper…
Biotech firms have been increasingly directing capital toward oncology therapeutics in recent years, reflecting a structural shift as companies recognize the significant commercial potential of precision oncology. According to BioPharma Di…
The primary distinction between VanEck Pharmaceutical ETF (NASDAQ:PPH) and VanEck Biotech ETF (NASDAQ:BBH) lies in their industry concentration and risk profiles, as one targets stable pharmaceutical leaders while the other focuses on biot…
Vertex Pharmaceuticals logo By Midea Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating cystic fibrosis (CF). Valued at $139 billion by market cap, the company invests…
The Invesco Pharmaceuticals ETF (NYSEMKT:PJP) provides broader pharmaceutical exposure and a higher dividend yield, while the VanEck Biotech ETF (NASDAQ:BBH) offers a more concentrated biotechnology play with a lower expense ratio. Healthc…
The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers lower costs and broader market diversification, while the VanEck Biotech ETF (NASDAQ:BBH) provides a more concentrated investment in 25 leading biotechnology companies. Both funds t…
The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and VanEck Biotech ETF (NASDAQ:BBH) offer targeted exposure to healthcare, with one focusing on established pharmaceutical giants and the other on high-growth genetic research firms. Both…
The biotechnology industry has been mounting a powerful rally, emerging as a standout performer in the equity market, which has otherwise been dominated by technology giants of late. Over the past year, the industry's resurgence has been f…
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…
Healthcare ETFs are hitting one-year highs because the sector is benefiting from a solid combination of improving earnings visibility, attractive relative valuations, and a rotation out of overcrowded AI/tech trades into defensive growth.…
Key Points Vanguard Health Care ETF offers a lower expense ratio and a higher dividend yield than VanEck Biotech ETF VanEck Biotech ETF holds a concentrated portfolio of 25 stocks, while Vanguard Health Care ETF provides broad exposure to…
Key Points iShares Global Healthcare ETF provides broader diversification with 110 holdings compared to 25 positions in VanEck Biotech ETF VanEck Biotech ETF delivered a 30.8% 1-year total return but has experienced a 39.9% historical maxi…
Comparing the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the VanEck Biotech ETF (NASDAQ:BBH) reveals two distinct fund profiles. IHE tracks established, blue chip pharmaceutical companies, while BBH zeroes in on the research-intens…
Key Points IHE pays a meaningfully higher dividend yield than BBH. BBH offers more concentrated exposure with 25 holdings, compared to 56 for IHE. Over the past five years, IHE has shown lower price volatility and experienced a much smalle…
Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers equal-weighted exposure to the broad healthcare sector, whereas VanEck Biotech ETF (NASDAQ:BBH) concentrates heavily on the 25 largest biotechnology companies. Investors ma…
Key Points Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of 0.35% while Invesco S&P 500 Equa…
Investors choosing between iShares U.S. Healthcare ETF (NYSEMKT:IYH) and VanEck Biotech ETF (NASDAQ:BBH) may weigh the broader, lower-volatility healthcare exposure of IYH against the concentrated, high-growth biotechnology focus of BBH. I…
Key Points iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries significantly greater historical pri…
Key Points State Street SPDR S&P Pharmaceuticals ETF provides exposure to 65 companies compared to the 25 holdings in VanEck Biotech ETF. VanEck Biotech ETF has experienced a deeper maximum drawdown of almost 40% over the last five years.…
The State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) offers broader exposure and lower historical volatility than the VanEck Biotech ETF (NASDAQ:BBH), which relies on a smaller group of biotechnology leaders. While both funds offer…
Choosing between a broad healthcare fund and a focused biotech fund comes down to how much risk -- and potential reward -- an investor is willing to take on. The Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and the VanEck Biotech ETF…
[Bubble] Petrovich9 The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left investors struggling to determine whether th…
In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global obesity rate has nearly tripled since…
Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating cystic fibrosis (CF). Valued at $109.2 billion by market cap, the company invests in scientific innovation to create…
Great Southern Copper PLC (LSE:GSCU, FRA:E9E) has hit big in Chile. A step-out hole returned up to 6.55% copper and 320 grams per tonne silver. The results suggest the Mostaza Fault Zone is bigger than first thought, and more drilling is p…
On February 17, 2026, Boxer Capital Management, LLC disclosed a new position in Terns Pharmaceuticals(NASDAQ:TERN), acquiring 375,000 shares in a transaction estimated at $15.15 million based on quarterly average pricing. What Happened Box…
[Young female scientist working in laboratory] Solskin Pharmaceutical (PJP [https://seekingalpha.com/symbol/PJP]), (XPH [https://seekingalpha.com/symbol/XPH]), (PPH [https://seekingalpha.com/symbol/PPH]) and biotechnology stocks (XBI [http…
Dublin, Feb. 13, 2026 (GLOBE NEWSWIRE) -- The "Institutional Custody Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The institutional custody services market is experiencing robust growth with projections…
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) jumped nearly 20% after positive interim results from its aged dog trial. Treated dogs showed better survival and muscle health, with no adverse events reported so far. IXICO PLC (AI…
Every quarter, Business Insider brings you expert views on how to invest $10,000 right now. With this update, we focused our questions through the lens of the market's biggest debate: Is AI a bubble? Many of the eight investing pros we spo…
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American…
VanEck Biotech ETF (BBH): How to Buy
[Businessman sets target analysis charts and graphs of developing stock market and global economic growth. Targeting growth ideas from large enterprise business valuations] If nominal GDP and earnings growth accelerate due to higher inflat…
* iShares Nasdaq Biotechnology ETF (NASDAQ:IBB [https://seekingalpha.com/symbol/IBB]) - $0.0828 [https://www.ishares.com/us/products/239699/]. * Payable Sep 19; for shareholders of record Sep 16; ex-div Sep 16. MORE ON ISHARES BIOTECHNOLOG…
The Chinese Yuan (CNH) is testing key support as mixed August inflation data highlights China’s struggle with deflation. Analysts see scope for gradual currency appreciation to boost household spending and support growth, BBH FX analysts r…
The global bond market rout stretched into a second day, weighing on equities, boosting gold prices to new highs, and lifting US Dollar (USD) against most currencies. The bond market sell-off reflects genuine concerns over fiscal profligac…